1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
ACADEMIA
Scientific Societies Urge Greater Caution for COVID Drug Use in Women of Childbearing Age
Scientific societies and other organizations on November 14 issued a joint statement urging healthcare providers to use special caution when prescribing and dispensing COVID-19 drugs contraindicated in expectant mothers for the treatment of women of childbearing age. The move comes…
To read the full story
Related Article
- More Pregnant Cases Reported for COVID Meds, Panel Urges Greater Caution
September 24, 2024
ACADEMIA
- Few Testing Facilities, Timing of Coverage Pose Challenge in CGP Testing in Japan: Oncologist
February 27, 2025
- Moves Being Made to Resolve Japan’s Drug Lag in Sarcoma: Oncologist
February 25, 2025
- 1st CP Inhibitor Approved for Sarcoma, Could This Be a Breakthrough to Treatment of More Subtypes?
February 25, 2025
- Oncologist Sees Need to Seek Middle Ground towards CGP Testing for 1st Line Therapy
February 17, 2025
- Lingering Shortage of Fentanyl Affecting Medical Practices: Pharmacist
February 13, 2025
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…